drugset / Trial / NCT00944580
A Vaccine Study for High Risk Cancers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and immunological effects of a vaccine for people diagnosed with high risk neuroblastoma, osteogenic sarcoma, and rhabdomyosarcoma. It is hypothesized that this vaccine could reduce the incidence of relapse.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-08
- Completion
- 2010-08
Outcome
Outcome not reported
Stopped (Enrollment): “unexpectedly low screening results leading to poor accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine | Vaccine | — | — |
| Background | Imiquimod | Other / unclassified | — | Topical |